Merck set to buy Prometheus Biosciences for around $11bn
Merck’s acquisition announcement could result in greater immunology treatments being developed for Crohn’s and IBD patients worldwide as soon as ...
Read moreDetailsMerck’s acquisition announcement could result in greater immunology treatments being developed for Crohn’s and IBD patients worldwide as soon as ...
Read moreDetailsThe unit Sheikh Shakhbout Medical City widens the treatment scope, including rare lymphoma of the skin. The unit Sheikh Shakhbout ...
Read moreDetailsThis magazine is newsworthy, analytical, and informative, providing readers with unique and professional content as well as opinions and editorials that will focus on medical and healthcare development. This specialty magazine is also the choice of healthcare professionals and informed readers who need an informed monthly source of news and information in the regional healthcare industry. We aim for excellence in our scientific, health and commercial reports.
© 2023 - ArabHealthWorld all rights reserved